Home LiteratureArticle Details
PMID: 1868081 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Refolded HIV-1 tat protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage.

Biochemistry ·Vol. 30 ·No. 32 ·1991-08-13 ·Pages 8060-6

Harper JW, Logsdon NJ

Abstract

Substantial evidence indicates that HIV-1 trans-activation by tat protein is mediated through the TAR RNA element. This RNA forms a stem-loop structure containing a three-nucleotide bulge and a six-nucleotide loop. Previous mutagenic analysis of TAR indicates that the bulge residues and a 4 bp segment of the stem constitute, in part, the tat binding site. However, there appears to be no sequence-specific contribution of the six-base loop. We have employed a ribonuclease protection technique to explore the interaction of tat with single-stranded regions of TAR. The results indicate that tat interacts with both the bulge and loop regions of TAR. Treatment of TAR RNA with RNase A results in cleavage at U23 and U31, located in the bulge and loop regions, respectively. High concentrations (approximately 2 microM) of Escherichia coli derived tat protein, prepared by standard procedures, gave complete protection of TAR RNA from RNase A cleavage. However, under these conditions, truncated TAR derivatives in which no stem-loop structure is expected to form were also protected, indicating nonspecific binding. In order to obtain a tat preparation with enhanced specificity toward TAR RNA, methods were developed for refolding the recombinant protein. This treatment enhanced the affinity of tat for TAR by approximately 30-fold [Kd(apparent) less than 25 nM] and markedly increased its specificity for the TAR. Again, tat protected TAR RNA from RNase A cleavage at both U23 and U31. Protection was also observed with RNase T1 which cleaves TAR RNA at three G residues in the six-base loop.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Amino Acid Sequence Base Sequence Carrier Proteins/genetics,metabolism Cloning, Molecular Escherichia coli/genetics Gene Products, tat/genetics,isolation & purification,metabolism HIV-1/genetics,metabolism Molecular Sequence Data Nucleic Acid Conformation RNA-Binding Proteins Recombinant Proteins/isolation & purification,metabolism Ribonucleases Transcription, Genetic tat Gene Products, Human Immunodeficiency Virus
Chemicals
Carrier Proteins Gene Products, tat RNA-Binding Proteins Recombinant Proteins tat Gene Products, Human Immunodeficiency Virus trans-activation responsive RNA-binding protein Ribonucleases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Harper J W
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030.
Logsdon N J
Article Info
Journal
Biochemistry
Abbr.
Biochemistry
ISSN
0006-2960
Published
1991-08-13
Pages
8060-6
Language
English
Region
United States
NLM ID
0370623
Subset
IM
Grants
NIAID NIH HHS · AI29833 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com